These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 5457417

  • 21. [Pruritus, only symptom of Hodgkin's disease for 5 years].
    Degos R, Civatte J, Blanchet P, Duterque M.
    Ann Med Interne (Paris); 1973 Mar; 124(3):235-8. PubMed ID: 4716717
    [No Abstract] [Full Text] [Related]

  • 22. Elevated plasma levels of a hydroxyproline-containing protein in Hodgkin's disease and their relation to disease activity.
    Leroy EC, Carbone PP, Sjoerdsma A.
    J Lab Clin Med; 1966 Jun; 67(6):891-7. PubMed ID: 5330920
    [No Abstract] [Full Text] [Related]

  • 23. [A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].
    Korolenko VO, Gershanovich ML, Tikhonova VV.
    Vopr Onkol; 2004 Jun; 50(4):421-5. PubMed ID: 15605764
    [No Abstract] [Full Text] [Related]

  • 24. [Experience with the management of patients with therapy-resistant Hodgkin's disease].
    Berényi E, Szegedi G.
    Orv Hetil; 1984 Nov 04; 125(45):2737-40, 2743. PubMed ID: 6548560
    [No Abstract] [Full Text] [Related]

  • 25. [Hodgkin's disease of primary pericardial origin].
    Bosa Ojeda F, de Armas Trujillo D, Marrero Rodríguez F, Laynez Cerdeña I, Domínguez Pastor C, Martín Herrera A, Hernández Nieto L.
    Med Clin (Barc); 1984 Jan 21; 82(2):74-6. PubMed ID: 6546775
    [No Abstract] [Full Text] [Related]

  • 26. [Combined therapy of lymphogranulomatosis].
    Vorob'ev AI, Fokina NT, Brilliant MD, Fil'kova EM.
    Probl Gematol Pereliv Krovi; 1981 Aug 21; 26(8):3-7. PubMed ID: 6895412
    [No Abstract] [Full Text] [Related]

  • 27. [Indications and therapeutic combinations in Hodgkin's disease].
    Malamos B.
    Rev Med Moyen Orient; 1967 Aug 21; 24(2):112-3. PubMed ID: 5248413
    [No Abstract] [Full Text] [Related]

  • 28. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
    Fiacchini M, Lauria F, Mazza P, Tura S.
    Haematologica; 1982 Jun 21; 67(3):394-401. PubMed ID: 6814996
    [No Abstract] [Full Text] [Related]

  • 29. ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
    Federico M, Luminari S, Iannitto E, Polimeno G, Marcheselli L, Montanini A, La Sala A, Merli F, Stelitano C, Pozzi S, Scalone R, Di Renzo N, Musto P, Baldini L, Cervetti G, Angrilli F, Mazza P, Brugiatelli M, Gobbi PG, HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
    J Clin Oncol; 2009 Feb 10; 27(5):805-11. PubMed ID: 19124807
    [Abstract] [Full Text] [Related]

  • 30. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ.
    Ai Zheng; 2007 Dec 10; 26(12):1360-4. PubMed ID: 18076802
    [Abstract] [Full Text] [Related]

  • 31. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG, Chandra A, Raman SG.
    Med Pediatr Oncol; 2003 Jan 10; 40(1):66-9. PubMed ID: 12426693
    [No Abstract] [Full Text] [Related]

  • 32. [Attemp at treatment of acute leukemia and Hodgkin's disease by rubidomycin or daunomycin alone or combined].
    Mathe G, Amiel JL, Hayat M, Schwarzenberg L, Schenider M, Cattan A, Schlumberger JR, Ceoara B.
    Sem Hop; 1967 Jul 10; 43(32):2108-14. PubMed ID: 4328374
    [No Abstract] [Full Text] [Related]

  • 33. [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
    Kolygin BA, Kharatishvili ZV.
    Vopr Onkol; 1983 Jul 10; 29(8):12-5. PubMed ID: 6688487
    [Abstract] [Full Text] [Related]

  • 34. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E, Doria R, Farber LR, Roberts KB, Cooper DL.
    Cancer J Sci Am; 1995 Jul 10; 1(4):267-73. PubMed ID: 9166487
    [Abstract] [Full Text] [Related]

  • 35. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF, Pro B, Fuller LM, Manning JT, Hagemeister FB, Romaguera J, Rodriguez MA, Ha CS, Smith TL, Ayala A, Hess M, Cox JD, Cabanillas F, McLaughlin P.
    J Clin Oncol; 2003 Jun 01; 21(11):2115-22. PubMed ID: 12775737
    [Abstract] [Full Text] [Related]

  • 36. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
    Neumann E.
    Wien Klin Wochenschr; 1981 Feb 20; 93(4):134-7. PubMed ID: 6895134
    [Abstract] [Full Text] [Related]

  • 37. Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
    Gibbs GE, Peterson BA, Kennedy BJ, Vosika G, Bloomfield CD.
    Arch Intern Med; 1981 Jun 20; 141(7):897-900. PubMed ID: 7235809
    [Abstract] [Full Text] [Related]

  • 38. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Al-Ali HK, Wittekind C, Niederwieser D.
    Dtsch Med Wochenschr; 2007 Aug 20; 132(33):1688-91. PubMed ID: 17713864
    [Abstract] [Full Text] [Related]

  • 39. [Chemotherapy of malignant lymphomas].
    Wasastjerna C.
    Duodecim; 1970 Aug 20; 86(16):931-7. PubMed ID: 5455656
    [No Abstract] [Full Text] [Related]

  • 40. [Use of prospidin in the combination chemotherapy of recurrences of generalized forms of lymphogranulomatosis].
    Vinokurova NA, Danova LA, Kondrat'ev VB, Gershanovich ML.
    Vopr Onkol; 1983 Aug 20; 29(7):46-50. PubMed ID: 6880132
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.